About House Rx
House Rx is a company based in San Francisco (United States) founded in 2005 by Ogi Kavazovic. House Rx has raised $84 million across 4 funding rounds from investors including Bessemer Venture Partners, 1984 Ventures and First Round Capital. House Rx operates in a competitive market with competitors including DecisionRx, Eurekam, Prescription Advisory Systems & Technology, GalenusRx and Pillcheck, among others.
- Headquarter San Francisco, United States
- Founders Ogi Kavazovic
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$84 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Bessemer Venture Partners
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of House Rx
Unlock access to complete
Unlock access to complete
Funding Insights of House Rx
House Rx has successfully raised a total of $84M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in House Rx
House Rx has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Bessemer Venture Partners, 1984 Ventures and First Round Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
|
Locked | Locked | Locked | |
|
Early-stage venture capital fund
|
Locked | Locked | Locked | |
|
US focused seed and early-stage VC firm
|
Locked | Locked | Locked |
Investor details for House Rx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by House Rx
Investment portfolio details for House Rx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - House Rx
Detailed financials for House Rx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
House Rx Comparisons
Peer comparison for House Rx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of House Rx
House Rx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DecisionRx, Eurekam, Prescription Advisory Systems & Technology, GalenusRx and Pillcheck, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medication management solutions are provided to patients and healthcare providers.
|
|
| Locked | Locked | Locked |
AI-based medication management solutions for oncology professionals are provided.
|
|
| Locked | Locked | Locked |
Software for Doctors to Help Treat Pain & Reduce Abuse of Controlled Substances
|
|
| Locked | Locked | Locked |
Medication safety risk management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
DNA testing platform for user medication responses is offered.
|
Detailed competitors of House Rx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on House Rx
Complete news archive for House Rx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about House Rx
House Rx was founded in 2005 and raised its 1st funding round 17 years after it was founded.
House Rx is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Ogi Kavazovic is the current CEO of House Rx. They have also founded this company.
House Rx is a funded company, having raised a total of $84M across 4 funding rounds to date.
House Rx was established in 2005 in San Francisco, United States, within the healthcare sector. Technology-driven solutions for medication management are offered to patients and caregivers, with emphasis on specialty pharmacy services. Access to medications is facilitated, adherence is supported through streamlined processes, and outcomes for patients and providers are enhanced. Operations target the United States market, addressing key challenges in medication delivery and monitoring.
House Rx's top competitors include DecisionRx, Eurekam and GalenusRx.
House Rx has 8 investors. Key investors include Bessemer Venture Partners, 1984 Ventures, First Round Capital, Character, and NEA.